AMIX

SEC source: 0001437749-26-030774 · rdgdoc.xml · nonDerivative · entry 1

Smith Trent N. · CIK 0001705689 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,119

F1 · price: Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

SEC source: 0001437749-26-029835 · rdgdoc.xml · nonDerivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,118

F1 · price: Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

SEC source: 0001437749-26-029833 · rdgdoc.xml · nonDerivative · entry 1

Bisson Lori · CIK 0001768578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,119

F1 · price: Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

SEC source: 0001437749-26-029830 · rdgdoc.xml · nonDerivative · entry 1

Hauser Bradley · CIK 0001662139 · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

F1 · price: Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

SEC source: 0001437749-25-026638 · rdgdoc.xml · derivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 8,773 shares

Expires 2034-06-21

F1 · derivative.exercise_price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F2 · balance_after: Amount represents a revised share amount based on a 1-for-20 reverse stock split from October 25,2024.

SEC source: 0001437749-25-026636 · rdgdoc.xml · derivative · entry 2

Smith Trent N. · CIK 0001705689 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 21,250 shares

Expires 2033-07-21

F1 · derivative.exercise_price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation.

F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation.

F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation.

F2 · balance_after: Amount represents a revised share amount based on a 1-for-20 reverse stock split from October 25, 2024.

SEC source: 0001437749-25-026636 · rdgdoc.xml · derivative · entry 1

Smith Trent N. · CIK 0001705689 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 11,405 shares

Expires 2034-06-21

F1 · derivative.exercise_price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation.

F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation.

F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received an additional three months severance as consideration for the cancellation.

SEC source: 0001437749-25-026641 · rdgdoc.xml · derivative · entry 1

Hauser Bradley · CIK 0001662139 · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,000 shares

Expires 2034-06-17

F1 · derivative.exercise_price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received three months severance as consideration for the cancellation.

F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received three months severance as consideration for the cancellation.

F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received three months severance as consideration for the cancellation.

SEC source: 0001437749-25-026637 · rdgdoc.xml · derivative · entry 2

Bisson Lori · CIK 0001768578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 46,680 shares

Expires 2033-06-30

F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · derivative.exercise_date: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F2 · balance_after: Amount represents a revised share amount based on a 1-for-20 reverse stock split from October 25,2024.

SEC source: 0001437749-25-026637 · rdgdoc.xml · derivative · entry 1

Bisson Lori · CIK 0001768578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,930

Underlying: Common Stock · 18,862 shares

Expires 2034-06-21

F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · derivative.exercise_date: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

SEC source: 0001437749-25-026640 · rdgdoc.xml · derivative · entry 1

Capelli Christopher · CIK 0001768585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,750 shares

Expires 2033-09-08

F1 · derivative.exercise_price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · shares: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

F1 · price: Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.

SEC source: 0001437749-24-021105 · rdgdoc.xml · derivative · entry 1

KLEMP WALTER V · CIK 0000938419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,452

Underlying: Common Stock · 175,452 shares

Expires 2034-06-21

F2 · price: Issued in connection with the reporting person's employment with the Company

F1 · derivative.exercise_date: The option set forth in this table vests in four annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

SEC source: 0001437749-24-021104 · rdgdoc.xml · derivative · entry 1

Smith Trent N. · CIK 0001705689 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 678,087

Underlying: Common Stock · 228,087 shares

Expires 2034-06-21

F2 · price: Issued in connection with the reporting person's employment with the Company

F1 · derivative.exercise_date: The option set forth in this table vests in four annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

SEC source: 0001437749-24-021106 · rdgdoc.xml · derivative · entry 1

Bisson Lori · CIK 0001768578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,335,821

Underlying: Common Stock · 377,221 shares

Expires 2034-06-21

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.

SEC source: 0001104659-24-073596 · tm2417717-1_4seq1.xml · derivative · entry 1

BioStar Ventures III, L.P. · CIK 0001577164 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,088,000

Underlying: Common Stock · 1,088,000 shares

Expires 2029-01-29

F1 · derivative.exercise_date: The ability of the Reporting Person to exercise the warrants is subject to a beneficial ownership limitation initially set at 4.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of common stock issuable upon exercise of the warrants. This beneficial ownership limitation may be increased or decreased at the election of the holder, provided that the beneficial ownership limitation in no event exceeds 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock upon exercise of the warrants and any increase shall not be effective until the 61st day after notice of adjustment is provided to the Issuer.

SEC source: 0001437749-24-023598 · rdgdoc.xml · derivative · entry 1

Robins David Andrew · CIK 0002007950 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 110,240

Underlying: Common Stock · 103,990 shares

Expires 2029-01-29

F1 · derivative.exercise_date: Includes a portion of 1,600,000 warrants to purchase shares of the Company's common stock that was held by Impulse Medical, Inc., in which Mr. Robins owns 19.5% through Portsmouth Therapeutics, Inc., an entity in which Mr. Robins also owns a 33.33% interest. The shares underlying the warrants are subject to a lockup agreement for a period of six months after January 29, 2024 with respect to 12.5% of the shares issued and twelve months after January 29, 2024 for the remainder of the shares.

F1 · ownership.direct: Includes a portion of 1,600,000 warrants to purchase shares of the Company's common stock that was held by Impulse Medical, Inc., in which Mr. Robins owns 19.5% through Portsmouth Therapeutics, Inc., an entity in which Mr. Robins also owns a 33.33% interest. The shares underlying the warrants are subject to a lockup agreement for a period of six months after January 29, 2024 with respect to 12.5% of the shares issued and twelve months after January 29, 2024 for the remainder of the shares.

SEC source: 0001437749-24-020871 · rdgdoc.xml · derivative · entry 1

Hauser Bradley · CIK 0001662139 · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Stock · 900,000 shares

Expires 2034-06-17

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.